Halozyme Therapeutics, Inc. (HALO)

69.17 +0.30 (+0.44%) USD  |  NASDAQ  |  Dec 29, 14:32
More

Halozyme Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Protalix Biotherapeutics, Inc. Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade